Plant-based Vaccines Market Size to Hit 12.9% CAGR, Globally, by 2028 - Exclusive Report by The Insight Partners
November 01, 2023 06:59 ET
|
The Insight Partners
Pune, India, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Plants are an important source to produce cost-effective vaccine derivatives. Plant-based vaccines can be made in a cost-effective way and produced on...
Emergent BioSolutions and Valneva Report Positive Phase 1 Results for Their Vaccine Candidate Against the Zika Virus
November 19, 2018 16:22 ET
|
Emergent BioSolutions
GAITHERSBURG, Md. and SAINT-HERBLAIN, France, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) and Valneva SE (VLA) today announced positive interim results for the Phase 1...
New Study Suggests Zika Virus Eradication in the Americas May Become Impossible, Making the Need for a Vaccine Even More Critical
November 05, 2018 10:04 ET
|
GeoVax, Inc.
GeoVax Comments on New Study Conducted in Brazil ATLANTA, GA, Nov. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human...
QualTex Laboratories Implements New Zika Testing Guidance from U.S. Food and Drug Administration
August 22, 2018 09:00 ET
|
BioBridge Global
San Antonio, Aug. 22, 2018 (GLOBE NEWSWIRE) -- QualTex Laboratories is up and running with new guidance for testing blood donations for the Zika virus, just weeks after the Food and Drug...
Emergent BioSolutions Initiates Phase 1 Clinical Study of Zika Virus Immune Globulin Therapeutic
July 31, 2018 16:30 ET
|
Emergent BioSolutions
ZIKV-IG granted Fast Track designation by the U.S. Food and Drug Administration GAITHERSBURG, Md., July 31, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the...
Article Co-authored by Spotlight Innovation Research Collaborator Describes Small Molecule Drugs with In-vivo Efficacy Against Zika Virus Infection
June 12, 2018 08:30 ET
|
Spotlight Innovation Inc.
URBANDALE, IA, June 12, 2018 (GLOBE NEWSWIRE) -- Spotlight Innovation Inc. (OTCQB: STLT), a pharmaceutical company targeting rare, emerging and neglected diseases, today announced that Company...
PositiveID Adds GenArraytion CEO R. Paul Schaudies, Ph.D. to its Board of Advisors
August 02, 2016 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Aug. 02, 2016 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today...
Zika virus discovery marks success of Purdue life sciences investment
March 31, 2016 14:05 ET
|
Purdue Research Foundation
West Lafayette, Ind., March 31, 2016 (GLOBE NEWSWIRE) -- Note to Journalists: A gallery of photos related to this news is available...
New Research from Phoenix Marketing's Mobile Experience Platform, mXP, Reveals that Women of Childbearing Age are No More Concerned about Zika Virus than Men
March 07, 2016 09:18 ET
|
Phoenix Marketing International
RHINEBECK, N.Y., March 7, 2016 (GLOBE NEWSWIRE) -- Phoenix Marketing International (http://phoenixmi.com/), a global marketing research firm, today revealed new insights from the company's mobile...
Mosquito Control Insecticides Market is Forecast to Spike Driven by the Zika Threat, According to Kline
February 29, 2016 10:02 ET
|
Kline & Company
PARSIPPANY, N.J., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Consumption of insecticides by professional mosquito control districts, which exhibits slower growth of 1.2% in 2015 over 2012, is forecast to spike...